RecruitingNot ApplicableNCT07348705

Electrophysiology-based DBS Programming for PD

Electrophysiology-based Deep Brain Stimulation Programming for Parkinson's Disease


Sponsor

University of Florida

Enrollment

30 participants

Start Date

Jan 15, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Deep brain stimulation (DBS) effectively alleviates motor symptoms in Parkinson's disease (PD). However, current programming is manual and time-consuming. This study will evaluate physiology-based programming using local field potentials (LFPs) to identify optimal stimulation parameters. Specifically, DBS contact selection based on beta power and a broad-band approach will be compared with conventional clinician-based programming.


Eligibility

Min Age: 21 YearsMax Age: 89 Years

Inclusion Criteria5

  • Patients with a diagnosis of idiopathic PD fulfilling the Movement Disorder Society Clinical Diagnostic Criteria for PD
  • DBS implantation with the Percept DBS device (Medtronic, USA) for the treatment of motor symptoms
  • Ability to give informed consent for the study
  • Willingness to do this study at the time of the initial programming session
  • Age 21 to 89 years old

Exclusion Criteria3

  • Inability to comply with the study protocol
  • Atypical Parkinsonism
  • Any personality or mood symptoms that study personnel believe will interfere with the study requirements

Interventions

DEVICEClinician-based DBS programming

Contacts, amplitude, pulse width, and frequency are chosen by the treating physician during a conventional monopolar review.

DEVICEMaximum Beta power-based DBS programming

The contact that shows the strongest beta activity (13-30 Hz) in the local field potentials is selected for stimulation.

DEVICEBroad-band electrophysiology-based DBS programming

A multi-frequency algorithm that integrates beta, theta/alpha, finely tuned gamma, and other relevant bands is used to identify the optimal contact.


Locations(1)

Norman Fixel Institute for Neurological Diseases

Gainesville, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07348705


Related Trials